fbpx
QQQ
+ 1.68
288.71
+ 0.58%
DIA
+ 3.81
292.13
+ 1.29%
SPY
+ 4.06
353.47
+ 1.14%
TLT
-1.07
161.84
-0.67%
GLD
-2.99
175.24
-1.74%

Blueberries Medical CEO Resigns

October 26, 2020 1:56 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Latin American cannabis producer Blueberries Medical (CSE:BBM) (OTCQB:BBRRF) announced on Monday the resignation of CEO Camilo Villalba.

Blueberries said Villalba will remain associated with the company as a consultant.

“I see such enormous potential both with the company and medicinal cannabis sector,” said Villalba. “However, some extremely unanticipated circumstances have arisen that have forced my hand, and I am unable to carry on. We have achieved tremendous milestones so far, and I would like to thank the board for having given me this opportunity." 

Executive Chairman Christian Toro has been appointed as Interim CEO.

The board stated they deem inappropriate to appoint a new CEO in the midst of the COVID-19 pandemic.

Blueberries will now place its focus on reducing costs and preserving capital. The company started a campaign to reduce administrative costs and operational expenditures at the start of the pandemic, and plans to continue along this line until revenues from cannabis sales starts coming in.

Registration of THC Cultivars: Blueberries is a licensed producer of medical cannabis with primary operation in Colombia. The company holds licenses to commercialize, manufacture and export THC-rich products and derivatives, and is currently on track to establish operations in Argentina.

On Monday, Blueberries also announced receiving approval from the Colombian Agricultural Institute to register its nine psychoactive THC-dominant strains with the national cultivar registry.

Courtesy Image


Related Articles

Cannabis Stock Gainers And Losers From November 23, 2020

GAINERS: Nine Energy Service (NYSE: NINE) shares closed up 34.15% at $2.20 read more

Cannabis Countdown: Top 10 Marijuana And Psychedelics Industry News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of November 16th – 22th, 2020. read more

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of November 16th – 22nd, 2020. Without further ado, let’s get started. read more

The Week In Cannabis: Stocks Outperform S&P, Mexico Moves Forward, Earnings, And More

Cannabis stocks outperformed the S&P 500 this week. Over the last five trading days: read more

Psyched: German Government Funds Psilocybin Study, Field Trip Opens Psilocybin Clinic

Global Developments in Germany, Canada and Brazil Germany has approved a large phase 2b study on psilocybin for treatment-resistant depression. read more